NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Bullish option flow detected in GSK (GSK) Pharma with 5,714 calls trading, 4x expected, and implied vol increasing over 5 points to 42.48%. Apr-25 38 calls and 4/4 weekly 37 puts are the most active ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

Aston Martins and Scotch whisky are likely to become more expensive in the US under Donald Trump. Car manufacturing and the ...

Genetic testing service 23andMe has filed for Chapter 11 bankruptcy protection to keep the company running while reorganizing ...

Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' ...

The broad STOXX 600 dropped to its lowest in two months and was last down 1.2%, but U.S. index futures fell more, around 3%, ...

Almost £8bn has been wiped off the value of the world’s biggest drugmakers after America’s leading vaccine official was ...

AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...